684 results on '"Singal, Amit G."'
Search Results
2. Effect of Hospital Cancer Designation on use of Multimodal Therapy and Survival of Metastatic Colorectal Cancer: A State-Wide Analysis
3. The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial
4. Evolving trends in CT colonography: A 10-year analysis of use and associated factors
5. PNPLA3, Obesity, and Heavy Alcohol Use in Cirrhosis Patients May Exert a Synergistic Increase Hepatocellular Carcinoma Risk
6. PKD1 mutant clones within cirrhotic livers inhibit steatohepatitis without promoting cancer
7. Advancing Surveillance Strategies for Hepatocellular Carcinoma: A New Era of Efficacy and Precision
8. Systemic Therapies for Hepatocellular Carcinoma in India
9. Financial Burden of Hepatocellular Carcinoma Screening in Patients With Cirrhosis
10. Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
11. A meta-analysis and real-world cohort study on the sex-related differences in efficacy and safety of immunotherapy for hepatocellular carcinoma
12. Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis
13. Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis
14. Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients with Unresectable HCC
15. Performance of a Multi-cancer Early Detection Test for Detection of Hepatocellular Carcinoma in Patients With Cirrhosis
16. COVID-19 Pandemic Impact on Diagnosis, Stage, and Treatment of Hepatocellular Carcinoma in the United States
17. Hepatocellular Carcinoma Surveillance: Evidence-Based Tailored Approach
18. Regional Differences in Clinical Presentation and Prognosis of Patients With Post–Sustained Virologic Response Hepatocellular Carcinoma
19. Risk Stratification Model for Hepatocellular Cancer in Patients With Cirrhosis
20. Effectiveness and safety of atezolizumab-bevacizumab in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis
21. Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference
22. Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era
23. Healthcare Costs for Medicare Patients With Hepatocellular Carcinoma in the United States
24. Breakthroughs in Hepatocellular Carcinoma Therapies
25. No Increase in Colorectal Cancer Screening in 2019 After American Cancer Society Recommends Starting Screening at Age 45
26. Disease Etiology and Outcomes After Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma: Post-Hoc Analysis of IMbrave150
27. Stool-Based Tests Mitigate Impacts of COVID-19 on Colorectal Cancer Screening
28. Clinical Outcomes of Patients With Suspicious (LI-RADS 4) Liver Observations
29. Racial, Ethnic, and Socioeconomic Disparities in Treatment Delay Among Patients With Hepatocellular Carcinoma in the United States
30. Correlation of LI-RADS 3 or 4 Observations with Histopathologic Diagnosis in Patients with Cirrhosis
31. Patient Navigation Increases Linkage to Care and Receipt of Direct-acting Antiviral Therapy in Patients with Hepatitis C
32. Racial and Ethnic Disparities in Barriers to Care in Patients with Hepatocellular Carcinoma
33. Risk of Hepatocellular Carcinoma in Patients With Indeterminate (LI-RADS 3) Liver Observations
34. Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease–Associated Hepatocellular Carcinoma in the United States
35. Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma
36. Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?
37. Colorectal Cancer Screening and Yield in a Mailed Outreach Program in a Safety-Net Healthcare System
38. Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid–enhanced MRI: long-term follow-up in a surveillance cohort
39. High Neutrophil–Lymphocyte Ratio and Delta Neutrophil–Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer
40. Multicenter Randomized Clinical Trial of a Mailed Outreach Strategy for Hepatocellular Carcinoma Surveillance
41. Cost Effectiveness of Mailed Outreach Programs for Colorectal Cancer Screening: Analysis of a Pragmatic, Randomized Trial
42. Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveillance in Patients With Cirrhosis
43. Characterization of Prevalent, Post-Endoscopy, and Incident Esophageal Cancer in the United States: A Large Retrospective Cohort Study
44. Prevalence of Forceps Polypectomy of Nondiminutive Polyps Is Substantial But Modifiable
45. Dynamic Changes in Ultrasound Quality for Hepatocellular Carcinoma Screening in Patients With Cirrhosis
46. Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis
47. Decreasing Trend of Serum α-Fetoprotein Level in Hepatocellular Carcinoma
48. A Conceptual Model for Implementation and Evaluation of Interventions Across the Hepatocellular Carcinoma Care Continuum
49. A Blood-Based Prognostic Liver Secretome Signature Predicts Long-term Risk of Hepatic Decompensation in Cirrhosis
50. Doylestown Plus and GALAD Demonstrate High Sensitivity for HCC Detection in Patients With Cirrhosis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.